Clare Market Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Clare Market Investments's BMY Position: Q3 2023 in Review
Clare Market Investments sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 4,849 shares — an estimated $310K sold.
Clare Market Investments first reported a position in BMY in Q4 2018 and held it in 19 quarters. The position peaked at $1.65M in Q2 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Clare Market Investments reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- Clare Market Investments sold 4,849 Bristol-Myers Squibb shares in Q3 2023, an estimated $310K.
- Clare Market Investments first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 19 quarters.
- Clare Market Investments's Bristol-Myers Squibb position peaked at $1.65M in Q2 2022.
- 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Clare Market Investments's 13F filing for Q3 2023, filed 20 Feb 2025.